Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription 20.05.2024 1 Abdom Radiol (NY) 1 Am J Nucl Med Mol Imaging 1 Appl Radiat Isot 1 Biomed Mater 1 Biotech Histochem 2 BMC Cancer 1 BMC Womens Health 2 BMJ 1 BMJ Open 5 Brachytherapy 1 Cancer Biol Ther 1 Cancer Cell Int 1 Cancer Commun (Lond) 1 Cancer Med 1 Cancer Sci 1 Cancer Treat Res Commun 2 Cancers (Basel) 1 ChemMedChem 1 Clin Exp Pharmacol Physiol 1 Cureus 1 Curr Probl Cancer 1 Discov Oncol 1 Eur J Clin Pharmacol 1 Eur J Public Health 1 Front Med (Lausanne) 2 Front Oncol 1 Front Public Health 2 Gene 1 Glob Public Health 1 Gynecol Oncol 1 Health Promot Int 1 Hematol Oncol Clin North Am 1 Hum Vaccin Immunother 1 Int J Cancer 2 Int J Gynaecol Obstet 1 Int J Mol Sci 1 J Am Soc Cytopathol 1 J Clin Virol 1 J Hazard Mater 1 J Med Virol 1 J Nat Med 1 J Pak Med Assoc 2 J Racial Ethn Health Disparities 1 J Radiat Res 1 JCO Glob Oncol 1 Kurume Med J 1 Lancet Reg Health Southeast Asia 1 Magn Reson Imaging 1 Minerva Med 1 Mol Biol Rep 2 N Engl J Med 1 Nutr Cancer 1 Phys Med Biol 1 PLOS Glob Public Health 1 PLoS One 1 Pol J Pathol 1 Prev Med 1 Public Health Nurs 1 Purinergic Signal 1 Reprod Biol 1 Reprod Sci 1 Rev Esp Enferm Dig 1 Sci Adv 2 Sci Rep 1 Spectrochim Acta A Mol Biomol Spectrosc 1 Syst Biol Reprod Med 1 Toxicon 2 Transl Cancer Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Abdom Radiol (NY)

1. LI XX, Liu B, Cui Y, Zhao YF, et al
   Intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced MRI for predicting parametrial invasion in cervical cancer.
   Abdom Radiol (NY). 2024 May 16. doi: 10.1007/s00261-024-04339.
   PubMed         Abstract available
   
   

   
   Am J Nucl Med Mol Imaging

2. CHEN X, Sun Y, Li F, Xi L, et al
   (68)Ga-labeled TMTP1 radiotracer for PET imaging of cervical cancer.
   Am J Nucl Med Mol Imaging. 2024;14:110-121.
   PubMed         Abstract available
   
   

   
   Appl Radiat Isot

3. ZHANG R, Bai J, Wang R, Yan J, et al
   Quantified difference of the collapsed cone convolution (CCC) and Monte Carlo (MC) algorithms based on DVH and gamma analysis for cervical cancer radiation therapy.
   Appl Radiat Isot. 2024;210:111340.
   PubMed         Abstract available
   
   

   
   Biomed Mater

4. CHEN Z, Liu W, Liu K, Wang S, et al
   Double-layer hollow mesoporous silica nanoparticles for ultrasound-guided photodynamic treatment.
   Biomed Mater. 2024;19.
   PubMed         Abstract available
   
   

   
   Biotech Histochem

5. KURDOGLU M, Kurdoglu Z, Kucukaydin Z, Erten R, et al
   Laminin receptor 1 expression in premalignant and malignant squamous lesions of the cervix.
   Biotech Histochem. 2024;99:174-181.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. WU Y, Jiang P, Chen Z, Li W, et al
   Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
   BMC Cancer. 2024;24:589.
   PubMed         Abstract available
   
   
7. LYONNAIS E, Vigoureux S, Blondel B, Wylomanski S, et al
   Women's country of birth and failure to catch up an overdue cervical cancer cytological screening participation during pregnancy in France, an observational study based on survey sources.
   BMC Cancer. 2024;24:595.
   PubMed         Abstract available
   
   

   
   BMC Womens Health

8. PENG J, Chen Y, Yin A
   JAM3 promotes cervical cancer metastasis by activating the HIF-1alpha/VEGFA pathway.
   BMC Womens Health. 2024;24:293.
   PubMed         Abstract available
   
   

   
   BMJ

9. FALCARO M, Soldan K, Ndlela B, Sasieni P, et al
   Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
   BMJ. 2024;385:e077341.
   PubMed         Abstract available
   
   
10. AMBOREE TL, Paguio J, Sonawane K
    HPV vaccine: the key to eliminating cervical cancer inequities.
    BMJ. 2024;385:q996.
    PubMed        
    
    

    
    BMJ Open

11. BOJE RB, Bardou M, Mensah K, Rico Berrocal R, et al
    What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries.
    BMJ Open. 2024;14:e079921.
    PubMed         Abstract available
    
    

    
    Brachytherapy

12. STENHOUSE K, Roumeliotis M, Ciunkiewicz P, Martell K, et al
    Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy.
    Brachytherapy. 2024;23:368-376.
    PubMed         Abstract available
    
    
13. LAI TS, Francoeur A, Manrriquez E, Venkat P, et al
    Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers.
    Brachytherapy. 2024;23:266-273.
    PubMed         Abstract available
    
    
14. SPORT C, Yarden N, Bale C, Mukhodpadhyay N, et al
    To who and by who: Discussions of sexual health, fertility, and premature menopause with women with locally advanced cervical cancer.
    Brachytherapy. 2024 May 10:S1538-4721(24)00066.
    PubMed         Abstract available
    
    
15. EWONGWO A, Niedermayr T, Kidd EA
    Design approach and benefits of the 3D-printed vaginal individualized applicator (VIA).
    Brachytherapy. 2024;23:282-289.
    PubMed         Abstract available
    
    
16. ROACH E, Hutten R, Johnson S, Suneja G, et al
    The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy.
    Brachytherapy. 2024;23:360-367.
    PubMed         Abstract available
    
    

    
    Cancer Biol Ther

17. LI L, Zeng J, He S, Yang Y, et al
    METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
    Cancer Biol Ther. 2024;25:2349429.
    PubMed         Abstract available
    
    

    
    Cancer Cell Int

18. WANG Y, Wang X, Liu Y, He Y, et al
    HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer.
    Cancer Cell Int. 2024;24:172.
    PubMed         Abstract available
    
    

    
    Cancer Commun (Lond)

19. LAN C, Lu H, Zhou L, Liao K, et al
    Long-term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study.
    Cancer Commun (Lond). 2024 May 13. doi: 10.1002/cac2.12547.
    PubMed         Abstract available
    
    

    
    Cancer Med

20. SU M, Liang Z, Shan S, Gao Y, et al
    Long non-coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/beta-catenin/PDK1 axis.
    Cancer Med. 2024;13:e7221.
    PubMed         Abstract available
    
    

    
    Cancer Sci

21. FUJII T, Nishio E, Tsukamoto T, Kukimoto I, et al
    Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.
    Cancer Sci. 2024 May 15. doi: 10.1111/cas.16214.
    PubMed         Abstract available
    
    

    
    Cancer Treat Res Commun

22. TESFAYE W, Ashine B, Yimer Y, Yismaw Y, et al
    Utilization of cervical cancer screening and determinant factors among female nurses in selected public hospitals in Addis Ababa, Ethiopia.
    Cancer Treat Res Commun. 2024;40:100815.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

23. WEAVER C, Nam A, Settle C, Overton M, et al
    Serum Proteomic Signatures in Cervical Cancer: Current Status and Future Directions.
    Cancers (Basel). 2024;16:1629.
    PubMed         Abstract available
    
    
24. MALLMANN MR, Tamir S, Alfter K, Ratiu D, et al
    Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer.
    Cancers (Basel). 2024;16:1787.
    PubMed         Abstract available
    
    

    
    ChemMedChem

25. LI J, Adobo SD, Shi H, Judicael KAW, et al
    Screening Methods for Cervical Cancer.
    ChemMedChem. 2024 May 12:e202400021. doi: 10.1002/cmdc.202400021.
    PubMed         Abstract available
    
    

    
    Clin Exp Pharmacol Physiol

26. HOU PX, Fan Q, Zhang Q, Liu JJ, et al
    M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
    Clin Exp Pharmacol Physiol. 2024;51:e13868.
    PubMed         Abstract available
    
    

    
    Cureus

27. CHEN J, Zhang R, Xu W, Bai L, et al
    Correction: Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study.
    Cureus. 2024;16:c174.
    PubMed         Abstract available
    
    

    
    Curr Probl Cancer

28. LAMI A, Alvisi S, Siconolfi A, Seracchioli R, et al
    Primary and secondary prevention of cervical cancer among Italian AFAB transgender people.
    Curr Probl Cancer. 2024;50:101103.
    PubMed         Abstract available
    
    

    
    Discov Oncol

29. ZHOU W, Song W, Lu M
    circ_0006789 promotes cervical cancer development via the miR-615-5p/HSF1 axis.
    Discov Oncol. 2024;15:165.
    PubMed         Abstract available
    
    

    
    Eur J Clin Pharmacol

30. JIAO XF, Li H, Zeng L, Yang H, et al
    Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank.
    Eur J Clin Pharmacol. 2024;80:855-867.
    PubMed         Abstract available
    
    

    
    Eur J Public Health

31. ZHANG M, Chen J, Cui M, Jia J, et al
    Analysis of the global burden of cervical cancer in young women aged 15-44 years old.
    Eur J Public Health. 2024 May 16:ckae084. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

32. ZENG S, Xiao S, Xu Y, Yang P, et al
    Efficacy and safety analysis of non-radical surgery for early-stage cervical cancer (IA2 ~ IB1): a systematic review and meta-analysis.
    Front Med (Lausanne). 2024;11:1337752.
    PubMed         Abstract available
    
    

    
    Front Oncol

33. ZHU X, Feng Y, Fan P, Dong D, et al
    Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer.
    Front Oncol. 2024;14:1381381.
    PubMed         Abstract available
    
    
34. SHANMUGAM A, Kvn K, Radhabai PR, Natarajan S, et al
    HO-SsNF: heap optimizer-based self-systematized neural fuzzy approach for cervical cancer classification using pap smear images.
    Front Oncol. 2024;14:1264611.
    PubMed         Abstract available
    
    

    
    Front Public Health

35. PARLAK B, Ugurlucan FG, Gokcay EG
    Actions speak louder than words; pediatricians, gynecologists, nurses, and other mothers' perspectives on the human papillomavirus vaccine: an Istanbul multicenter study.
    Front Public Health. 2024;12:1361509.
    PubMed         Abstract available
    
    

    
    Gene

36. KONG X, Xiong Y, Li L
    LINC01605 promotes malignant phenotypes of cervical cancer via miR-149-3p/WNT7B axis.
    Gene. 2024;921:148518.
    PubMed         Abstract available
    
    
37. QIN J, Chen Y, Zhao X, Yu J, et al
    circCUL3 drives malignant progression of cervical cancer by activating autophagy through sponge miR-223-3p upregulation of ATG7.
    Gene. 2024 May 15:148572. doi: 10.1016/j.gene.2024.148572.
    PubMed         Abstract available
    
    

    
    Glob Public Health

38. CHOWDHURY MZI, Mubin N, Mohib T, Chowdhury N, et al
    Cancer screening research in Bangladesh: Insights from a scoping review.
    Glob Public Health. 2024;19:2351186.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

39. HUNSBERGER KS, Treiman S, Monk BJ, Tewari KS, et al
    A systematic review of stage IVA cervical cancer treatment: Challenges in the management of an understudied group.
    Gynecol Oncol. 2024;187:120-127.
    PubMed         Abstract available
    
    

    
    Health Promot Int

40. MATHOMA A, Sartorius B, Mahomed S
    Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022-2023.
    Health Promot Int. 2024;39:daae042.
    PubMed         Abstract available
    
    

    
    Hematol Oncol Clin North Am

41. SAHASRABUDDHE VV
    Cervical Cancer: Precursors and Prevention.
    Hematol Oncol Clin North Am. 2024 May 16:S0889-8588(24)00032.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

42. WANG M, Liang H, Yan Y, Bian R, et al
    Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review.
    Hum Vaccin Immunother. 2024;20:2343192.
    PubMed         Abstract available
    
    

    
    Int J Cancer

43. HANSEN BT, Nygard M, Castle PE, Burger EA, et al
    Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway.
    Int J Cancer. 2024 May 15. doi: 10.1002/ijc.34989.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

44. WANG R, Ma L, Xiao Y, Jiang H, et al
    A case of postoperative non-invasive mucosal implantation of early-stage cervical adenocarcinoma to the clitoris.
    Int J Gynaecol Obstet. 2024;165:1295-1297.
    PubMed        
    
    
45. YANG ST, Liu HH, Liu CH, Wang LW, et al
    Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy.
    Int J Gynaecol Obstet. 2024 May 15. doi: 10.1002/ijgo.15609.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

46. MARK ZA, Yu L, Castro L, Gao X, et al
    Tobacco Smoke Condensate Induces Morphologic Changes in Human Papillomavirus-Positive Cervical Epithelial Cells Consistent with Epithelial to Mesenchymal Transition (EMT) with Activation of Receptor Tyrosine Kinases and Regulation of TGFB.
    Int J Mol Sci. 2024;25:4902.
    PubMed         Abstract available
    
    

    
    J Am Soc Cytopathol

47. GOETZ LH, Evans HL, Armylagos D, Zhou H, et al
    Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.
    J Am Soc Cytopathol. 2024;13:227-232.
    PubMed         Abstract available
    
    

    
    J Clin Virol

48. POLJAK M, Ostrbenk Valencak A, Cuschieri K, Bohinc KB, et al
    2023 global inventory of commercial molecular tests for human papillomaviruses (HPV).
    J Clin Virol. 2024;172:105671.
    PubMed         Abstract available
    
    

    
    J Hazard Mater

49. ZHANG X, Yan W, Chen X, Li X, et al
    Long-term 4-nonylphenol exposure drives cervical cell malignancy through MAPK-mediated ferroptosis inhibition.
    J Hazard Mater. 2024;471:134371.
    PubMed         Abstract available
    
    

    
    J Med Virol

50. RIZZO A, Dalu D, Moschese D, Giacomelli A, et al
    Eliminating cervical cancer: Don't forget HPV test and vaccination in men.
    J Med Virol. 2024;96:e29677.
    PubMed        
    
    

    
    J Nat Med

51. CHEN P, Zhang X, Fang Q, Zhao Z, et al
    Betulinic acid induces apoptosis of HeLa cells via ROS-dependent ER stress and autophagy in vitro and in vivo.
    J Nat Med. 2024;78:677-692.
    PubMed         Abstract available
    
    

    
    J Pak Med Assoc

52. IDRAK S, Zaki S, Rasheed F, Javed M, et al
    Cervical cancer screening practices in HIV positive females - a missing link in health care delivery in Pakistan.
    J Pak Med Assoc. 2024;74:631-640.
    PubMed         Abstract available
    
    

    
    J Racial Ethn Health Disparities

53. CHAN DNS, Lee PPK, So WKW
    Exploring the Barriers and Facilitators Influencing Human Papillomavirus Vaccination Decisions Among South Asian and Chinese Mothers: a Qualitative Study.
    J Racial Ethn Health Disparities. 2024;11:1465-1477.
    PubMed         Abstract available
    
    
54. ADEBOLA A, Adaeze A, Adeyimika D, Lovoria WB, et al
    Experiences and Challenges of African American and Sub-Saharan African Immigrant Black Women in Completing Pap Screening: a Mixed Methods Study.
    J Racial Ethn Health Disparities. 2024;11:1405-1417.
    PubMed         Abstract available
    
    

    
    J Radiat Res

55. MIYATA Y, Ogo E, Murotani K, Tsuda N, et al
    Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the 'adjusted dose score'.
    J Radiat Res. 2024 May 13:rrae031. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    JCO Glob Oncol

56. BACORRO W, Short M, Baldivia K, Mariano J, et al
    Shared Decision Making in Oncology and Its Implementation in Cervical Cancer Management in the Philippines: A Narrative Review.
    JCO Glob Oncol. 2024;10:e2300486.
    PubMed         Abstract available
    
    

    
    Kurume Med J

57. NASU H, Nishio S, Park J, Tasaki K, et al
    Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.
    Kurume Med J. 2024;69.
    PubMed         Abstract available
    
    

    
    Lancet Reg Health Southeast Asia

58. SATHISHKUMAR K, Sankarapillai J, Mathew A, Nair RA, et al
    Survival of patients with cervical cancer in India - findings from 11 population based cancer registries under National Cancer Registry Programme.
    Lancet Reg Health Southeast Asia. 2023;24:100296.
    PubMed         Abstract available
    
    

    
    Magn Reson Imaging

59. LIU Y, Dong TF, Li PJ, Chen LB, et al
    MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
    Magn Reson Imaging. 2023 Nov 28:S0730-725X(23)00198.
    PubMed         Abstract available
    
    

    
    Minerva Med

60. CHENG Q, Fan S, Xu J, Zhou H, et al
    Analysis of the impact of introspective therapy on the psychological state and family functioning of cervical cancer patients with anxiety.
    Minerva Med. 2024 May 15. doi: 10.23736/S0026-4806.24.09256.
    PubMed        
    
    

    
    Mol Biol Rep

61. HUANG M, Hu J, Chen Y, Xun Y, et al
    Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage phenotype.
    Mol Biol Rep. 2024;51:654.
    PubMed         Abstract available
    
    

    
    N Engl J Med

62. PLANTE M, Mahner S, Ferron G
    Simple versus Radical Hysterectomy for Low-Risk Cervical Cancer. Reply.
    N Engl J Med. 2024;390:1833.
    PubMed        
    
    
63. CIBULA D, Falconer H, Kohler C
    Simple versus Radical Hysterectomy for Low-Risk Cervical Cancer.
    N Engl J Med. 2024;390:1832-1833.
    PubMed        
    
    

    
    Nutr Cancer

64. ZHANG L, Liu W, Li Y, Fu Y, et al
    Polyphyllin I Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment.
    Nutr Cancer. 2024 May 10:1-10. doi: 10.1080/01635581.2024.2350107.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

65. CHENG J, Zhao B, Liu Z, Huang D, et al
    DMGM: deformable-mechanism based cervical cancer staging via MRI multi-sequence.
    Phys Med Biol. 2024 May 15. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    

    
    PLOS Glob Public Health

66. KASSA RN, Shifti DM, Alemu K, Omigbodun AO, et al
    Integration of cervical cancer screening into healthcare facilities in low- and middle-income countries: A scoping review.
    PLOS Glob Public Health. 2024;4:e0003183.
    PubMed         Abstract available
    
    

    
    PLoS One

67. SHIMELS T, Gashawbeza B, Fenta TG
    Validation of the Amharic version of perceived access to healthcare services for patients with cervical cancer in Ethiopia: A second-order confirmatory factor analysis.
    PLoS One. 2024;19:e0300815.
    PubMed         Abstract available
    
    

    
    Pol J Pathol

68. PIOTROWSKI PG, Jelen MT
    Retrospective analysis of negative cytology results correlated with a positive high-risk in the human papillomavirus result and subsequent results of patients over a period of three years.
    Pol J Pathol. 2024;75:36-39.
    PubMed         Abstract available
    
    

    
    Prev Med

69. REICH O, Regauer S
    Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer.
    Prev Med. 2024 May 15:108006. doi: 10.1016/j.ypmed.2024.108006.
    PubMed        
    
    

    
    Public Health Nurs

70. DEVI S, Gangarde R, Deokar S, Muqeemuddin SF, et al
    Public health nurse perspectives on predicting nonattendance for cervical cancer screening through classification, ensemble, and deep learning models.
    Public Health Nurs. 2024 May 17. doi: 10.1111/phn.13334.
    PubMed         Abstract available
    
    

    
    Purinergic Signal

71. FARIA PCL, Resende RS, Cardoso AM
    Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets.
    Purinergic Signal. 2024 May 16. doi: 10.1007/s11302-024-10020.
    PubMed         Abstract available
    
    

    
    Reprod Biol

72. ZHANG Z, Zhou X, Li J, Meng Q, et al
    LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.
    Reprod Biol. 2024;24:100893.
    PubMed         Abstract available
    
    

    
    Reprod Sci

73. HUANG J, Zhao Y
    Effect of GLIS1 on the Lymph Node Metastasis of Cervical Squamous Carcinoma Based on Transcriptome Analysis.
    Reprod Sci. 2024;31:1332-1344.
    PubMed         Abstract available
    
    

    
    Rev Esp Enferm Dig

74. JARA FERNANDEZ L, Ferrer JA, Perez Calle JL, Lopez Serrano P, et al
    Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study.
    Rev Esp Enferm Dig. 2024;116:292-293.
    PubMed         Abstract available
    
    

    
    Sci Adv

75. SONG H, Jiang H, Hu W, Hai Y, et al
    Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids.
    Sci Adv. 2024;10:eadl3511.
    PubMed         Abstract available
    
    

    
    Sci Rep

76. MATHIVANAN SK, Francis D, Srinivasan S, Khatavkar V, et al
    Enhancing cervical cancer detection and robust classification through a fusion of deep learning models.
    Sci Rep. 2024;14:10812.
    PubMed         Abstract available
    
    
77. HALLE MK, Hodneland E, Wagner-Larsen KS, Lura NG, et al
    Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
    Sci Rep. 2024;14:11339.
    PubMed         Abstract available
    
    

    
    Spectrochim Acta A Mol Biomol Spectrosc

78. FAN Q, Ding H, Mo H, Tang Y, et al
    Cervical cancer biomarker screening based on Raman spectroscopy and multivariate statistical analysis.
    Spectrochim Acta A Mol Biomol Spectrosc. 2024;317:124402.
    PubMed         Abstract available
    
    

    
    Syst Biol Reprod Med

79. JIN R, Li H, Nan S, Wang H, et al
    FOXA1 co-activates circODC1 and ODC1 in HPV-positive cervical cancer cell growth.
    Syst Biol Reprod Med. 2024;70:113-123.
    PubMed         Abstract available
    
    

    
    Toxicon

80. GUILLEN-MELENDEZ GA, Perez-Hernandez RA, Chavez-Montes A, Castillo-Velazquez U, et al
    Nanoencapsulation of Extracts and Isolated Compounds of Plant Origin and Their Cytotoxic Effects on Breast and Cervical Cancer Treatments: Advantages and New Challenges.
    Toxicon. 2024 May 11:107753. doi: 10.1016/j.toxicon.2024.107753.
    PubMed         Abstract available
    
    

    
    Transl Cancer Res

81. ZOU J, Li Y, Chen T, Zhu C, et al
    An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer.
    Transl Cancer Res. 2024;13:1876-1886.
    PubMed         Abstract available
    
    
82. HE JY, Li ZM, Chen YT, Zhao BH, et al
    Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
    Transl Cancer Res. 2024;13:1721-1736.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.